ARID1A and mismatch repair cancer syndrome 1: Although some in vivo studies suggested that ARID1A downregulation might mediate modest rather than global DNA methylation regulation early in tumorigenesis (40, 41), it is not completely clear if ARID1A mutation is the result or the cause of MMR deficiency secondary to promoter hypermethylation, especially in ECs.